Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.
Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment.
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Fumaric acid esters prevent the NLRP3 inflammasome-mediated and ATP-triggered pyroptosis of differentiated THP-1 cells.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Multiple sclerosis: Could Helicobacter pylori provide protection against multiple sclerosis?
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
10 years of interferon beta-1b (Beta feron therapy.
Immunology of Multiple Sclerosis.
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
Multiple Sclerosis: An Update.
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis.
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.

Pages